cipla news
Latest from cipla
Fans question if Pat Cummins is leaving IPL 2025 midway after his wife's post
Australian cricketer Pat Cummins' wife shared a photo with her husband from the Mumbai Airport on Friday.
Published on Apr 19, 2025 12:48 PM IST
Samarth Goyal
Hardik Pandya's rumoured gf Jasmin Walia boards MI bus after clash against KKR
Jasmin Walia's sighting at MI Vs KKR clash has fueled widespread speculation that her rumored relationship with Hardik Pandya is more than just gossip.
Updated on Apr 01, 2025 01:26 AM IST
Samarth Goyal
Rahul Dravid forced to stop IPL auction planning; tracks India's comeback vs AUS
Rahul Dravid stopped the auction planning midway to check how things are unfolding in Perth in the first Test between India and Australia.
Updated on Nov 23, 2024 08:00 AM IST
Cipla share price falls the most among Nifty companies
Cipla share price fell the most in terms of percentage among all the 50 companies in the NSE Nifty today
Updated on Oct 30, 2024 11:51 AM IST
Three held in Ggm Sector 39 over counterfeit arthritis drug
The officials said the counterfeit drug in question was Tofajak, which is used to treat arthritis and is manufactured by pharmaceutical giant Cipla.
Updated on Sep 26, 2024 06:39 AM IST
Cipla's vice-chairman MK Hamied resigns citing age, his son Kamil to join board
Cipla's MK Hamied resigned due to age and health. Kamil Hamied is appointed as Non-Executive Director starting November 1, 2024.
Published on Sep 04, 2024 07:22 AM IST
PTI |
SRK for retention, Ness for auction: IPL franchise owners spar at BCCI meeting
Shah Rukh Khan and Ness Wadia met on Wednesday night at the BCCI headquarters to plan the upcoming IPL season
Published on Aug 01, 2024 04:38 PM IST
Shreyas Iyer and Pat Cummins exchange fiery notes ahead of mega IPL 2024 final
Cummins will look to emulate his Aussie teammate Warner, who led SRH to the IPL title in 2016. However, KKR has posed a tough challenge in the past.
Published on May 26, 2024 04:01 PM IST
KL Rahul like ‘corporate majdoor with boss’: Internet on Sanjiv Goenka video
LSG vs SRH: Sanjiv Goenka was seen in a viral video having an animated discussion with Lucknow Super Giants skipper KL Rahul near the LSG dugout.
Updated on May 09, 2024 10:56 AM IST
Stocks to watch on March 27: Cipla, Hinduja Group, Raymond, Wipro and more
Stocks to watch on March 27: Look out for Raymond stock as company said that it will expand its business across all its three verticals. Check full list here
Published on Mar 27, 2024 08:10 AM IST
Close to committing $1 billion to Moderna for Covid-19 booster shot: Cipla
Cipla requests government for indemnification and exemptions from price capping, bridging trials and basic customs duty.
Published on Jun 01, 2021 03:48 AM IST
PTI | , Hindustan Times, New Delhi
Moderna shot likely next year; Pfizer to offer 50 million jabs
While Moderna has conveyed to Indian authorities that it does not have surplus vaccines to share in 2021, there are limited prospects of Johnson & Johnson exporting its jabs from the US to other countries in the near future, the people added.
Published on May 26, 2021 04:06 AM IST
PTI | , New Delhi
Cipla's real-time Covid-19 testing kit 'ViraGen' to be sold from today
The Covid-19 detection kit is approved by the ICMR (Indian Council of Medical Research) and uses multiplex PCR technology.
Published on May 25, 2021 07:08 AM IST
Written by Prashasti Singh, Hindustan Times, New Delhi
Roche India launches first batch of antibody cocktail for treating Covid-19
In a joint statement with Cipla, Roche India said that the second batch of the Covid-19 drug will be made available by mid-June. The cost of each dose, the statement said, will be ₹59,750.
Published on May 24, 2021 11:48 AM IST
hindustantimes.com | Edited by Karan Manral, New Delhi
India's Cipla says supply of Covid-19 drug remdesivir catching up with demand
Cipla, one of India's oldest drug manufacturers, has a deal to make and supply remdesivir to more than 100 countries.
Published on May 15, 2021 08:22 PM IST
Reuters |
Cipla, Lupin, Sun Pharma sign deals to make Lilly’s Covid drug
These voluntary licensing pacts will ensure high-quality manufacturing and accessibility of baricitinib during the pandemic, improving the local treatment options available to those battling by the deadly infection, the company said in a statement.
Published on May 11, 2021 07:00 AM IST
Livemint | Neetu Chandra Sharma, New Delhi
Cipla to make, sell Eli Lilly's baricitinib for Covid-19 treatment
In November, the US Food and Drug Administration initially gave Eli Lilly an emergency use approval for baricitinib in combination with Remdesivir to treat Covid-19 patients.
Published on May 10, 2021 10:05 AM IST
Reuters | , Bengaluru
'Unprecedented demand': Cipla doubles Remdesivir output as Covid-19 cases surge
India has overtaken Brazil as the world's second-worst coronavirus-hit country after the United States, having administered about 107 million vaccine doses among a population of 1.4 billion.
Published on Apr 13, 2021 02:02 PM IST
Reuters |